VOYA Investment Management
NEOS

VOYA Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

VOYA Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,185
Closed -$47K – 2637
2019
Q1 		$47K Buy
18,185
+3,220
+22% +$7.55K ﹤0.01% 2513
2018
Q4 		$25K Buy
14,965
+4,175
+39% +$11.7K ﹤0.01% 2531
2018
Q3 		$52K Hold
10,790
– – ﹤0.01% 2566
2018
Q2 		$67K Hold
10,790
– – ﹤0.01% 2581
2018
Q1 		$90K Hold
10,790
– – ﹤0.01% 2487
2017
Q4 		$110K Buy
+10,790
New +$104K ﹤0.01% 2485

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's NEOS Position: Q2 2019 in Review

VOYA Investment Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 18,185 shares — an estimated $47K sold.

VOYA Investment Management first reported a position in NEOS in Q4 2017 and held it in 6 quarters. The position peaked at $110K in Q4 2017. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • VOYA Investment Management reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • VOYA Investment Management sold 18,185 Neos Therapeutics, Inc shares in Q2 2019, an estimated $47K.
  • VOYA Investment Management first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 6 quarters.
  • VOYA Investment Management's Neos Therapeutics, Inc position peaked at $110K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on VOYA Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.